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Normal preoperative white blood cell count is
predictive of outcomes for endovascular
procedures
Daniel J. Amaranto, BA, Edward C. Wang, PhD, Mark K. Eskandari, MD, Mark D. Morasch, MD,
Heron E. Rodriguez, MD, William H. Pearce, MD, and Melina R. Kibbe, MD, Chicago, Ill
Background: An abnormally elevated preoperative white blood cell count (WBC) has been associated with postoperative
morbidity and mortality. However, it is unknown if a normal WBC is predictive of postoperative outcomes following
vascular interventions. Thus, the objective of this study is to determine if a WBC within the normal range is predictive of
outcomes following vascular interventions.
Methods: The medical records of patients undergoing endovascular and open repair of carotid stenosis, aortic aneurysm,
and peripheral arterial disease from 1999 to 2009 were retrospectively reviewed. Major adverse events (MAE) were
defined as death, stroke, and myocardial infarction.
Results: Of 1773 cases with normal preoperative WBC (3.5-10.5 K/L), there were 804 [45.3%] endovascular and 969
[54.7%] open vascular surgeries. Patients with complications (55) or MAE (19) after endovascular intervention had
higher preoperative WBC compared with patients without complications (WBC 7.7  1.47 vs 7.1  1.57, respectively,
P .002) or MAE (WBC 8.3 1.26 vs 7.1 0.06, respectively, P .001). No difference was observed for patients who
received open surgery. Patients undergoing endovascular intervention were 2.3, 4.8, and 22 times more likely to
experience complications (P .004), MAE (P .003), or death (P .036) whenWBC exceeded 7.5 K/L. Multivariate
analysis showed that preoperative normal WBC was an independent predictor of complications, MAE, and death in
patients after endovascular procedures but only for death in patients after open vascular procedures.
Conclusions: This study demonstrates a strong linear correlation between an increasing preoperative WBC within the
normal range and an increased risk for postoperative complications and death following endovascular interventions. The
study also found a significant curvilinear U-shaped relation between a normal preoperative WBC and death in the open
surgical cohort, with patients in the very low and very high normal WBC range at an increased risk of death. (J Vasc Surg
2011;54:1395-403.)
d
a
c
f
a
b
b
d
n
c
C
f
K
W
(
s
n
u
(
b
i
t
u
wLike other major inflammatory markers, the white
blood cell count (WBC) has been linked to the onset of
cardiovascular disease, and has been shown to be a predic-
tor of future cardiovascular events in healthy individuals as
well as all-cause and cancer-related mortality.1,2 An abnor-
mally elevated WBC (10.5 K/L) has also been associ-
ated with worse outcomes following open and endovascu-
lar intervention of cardiovascular and peripheral arterial
disease (PAD).3-7 For example, analyses of preoperative
WBC have shown correlation between abnormally elevated
WBC and short- and long-termmortality, as well as general
complications following open cardiac surgery.3,5,7 Abnor-
mally low preoperative WBC has also been shown to cor-
relate with mortality following percutaneous coronary in-
tervention (PCI).6 Furthermore, depletion of leukocytes
From the Division of Vascular Surgery, Northwestern University, Feinberg
School of Medicine.
Competition of interest: none.
Additional material for this article may be found online at www.jvascsurg.org
Reprint requests: Melina R. Kibbe, MD, Northwestern University, Division
of Vascular Surgery, 676 N St Clair Street, Suite 650, Chicago, IL 60611
(e-mail: mkibbe@nmh.org).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00t
Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.
doi:10.1016/j.jvs.2011.04.063uring cardiac surgery was shown to reduce the postoper-
tive inflammatory response and improve lung-gas ex-
hange.8 Additionally, there is evidence that complications
ollowing endovascular intervention for PAD are greater
mong patients with abnormally high WBC.9 Thus, a link
etween an abnormal WBC and significant health risks has
een well-established by many studies over the past several
ecades.
There is considerable variation in the definition of
ormal WBC. Normal WBC is defined in Harrison’s Prin-
iples of Internal Medicine as 4.3 to 10.8 K/L, while the
enter for Disease Control uses different reference ranges
or men (3.9-12.5 K/L) and for women (3.9-12.1
/L).10,11 Factors that affect what is considered normal
BC include pregnancy, chronic inflammatory diseases
eg, systemic lupus erythematosus), or the presence of
teroids. Despite the variability, for statistical purposes we
eeded to decide upon a single range. For our study, we
sed the range defined by the laboratory at our hospital
3.5-10.5 K/L).
An area that has not been studied is the association
etween a normal WBC and outcomes following surgical
nterventions. Several reviews have brought attention to
he need to investigate WBC.12-16 The WBC may be an
nderutilized predictive index in patients, suggesting
hich patients may be at an increased risk of complica-
ions related to a heightened systemic inflammatory re-
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November 20111396 Amaranto et alsponse.3-7,9,17-21 Thus, the aim of this study is to exclu-
sively examine the association between a normal
preoperative WBC and outcomes following endovascular
and open vascular procedures and determine if postoperative
complications are predicted by an increasing preoperative
WBC within the normal range. We hypothesized that an
increased preoperative WBC exclusively within the normal
range predicts an increased risk of postoperative complications
in patients undergoing vascular interventions.
METHODS
Patient cohort. This study was approved by the Insti-
tutional Review Board at Northwestern University. Adults
who underwent carotid endarterectomy (CEA), carotid
artery stenting (CAS), open repair of abdominal aortic
aneurysm (AAA), endovascular repair of abdominal aor-
tic aneurysm (EVAR), open repair of thoracoabdominal
aortic aneurysm (TAAA), endovascular repair of thoraco-
abdominal aneurysm (TEVAR), lower extremity bypass
grafting (LEB), or lower extremity stenting (LES) by at-
tending physicians in the Division of Vascular Surgery at
Northwestern Memorial Hospital from April 1, 1999 to
May 31, 2009 comprised the population for this study.
Patients without preoperative WBC or with preoperative
WBC outside the normal range (3.5-10.5 K/L) deter-
mined by Northwestern Memorial Hospital were excluded
from analysis. Patients who received major surgical inter-
vention within 30 days before or after their index vascular
procedure were also excluded from the analysis. Only the
most recent WBC taken before the procedure was re-
corded.
Patient demographics and outcomes. Data were ret-
rospectively collected from a prospectively maintained da-
tabase. These included demographics (age and gender),
comorbidities (diabetes, congestive heart failure [CHF],
myocardial infarction [MI], renal insufficiency, hyperten-
sion, and hyperlipidemia), preoperative laboratory values,
and preoperative emergent vs nonemergent status. Postop-
erative complications included death, stroke, MI, transient
ischemic attack (TIA), infection, bleeding, reoperation,
and amputation were collected from the medical record.
Postoperative major adverse events (MAE) were defined as
death, stroke, and MI.
Statistical analysis. Patients were separated into an
endovascular cohort comprised of CAS, EVAR, TEVAR,
and LES, and an open cohort comprised of CEA, AAA,
TAAA, and LEB. Analyses of individual procedures were
also performed. Data were summarized using descriptive
statistics (eg, means and standard deviation for continuous
variables; count and frequency for categorical variables).
Patient demographics, comorbidities, and preoperative
emergent status between endovascular and open vascular
cohorts were compared using a Student t test for continu-
ous variables or 2 test for categorical data. Both univariate
and multivariate analyses were conducted to assess the
effect of WBC on postoperative complications. Preopera-
tive WBC (reported as mean  standard deviation) was
compared in relation to each postoperative outcome by 1tudent t tests, and the risk ratios for postoperative com-
lications across increasing subgroups of WBC (3.5-4.4
/L, 4.5-5.4 K/L, etc) were determined using univar-
ate logistic regression. The Cochran-Armitage trend test
as conducted to examine the linear trend between the
BC and postoperative outcomes. When a nonlinear trend
as observed, the tests for curvilinear trend were also
onducted by adding a quadratic term for WBC to the
tatistical model. Finally, multivariate logistic regression
as performed to identify independent predictors of out-
omes. All statistical analyses were performed using SAS 9.2
tatistical software (SAS Inc, Cary, NC) and differences
ere considered significant for two-sided  level 0.05.
ESULTS
Patient demographics. In total, 2807 cases were per-
ormed by the Division of Vascular Surgery at Northwest-
rn Memorial Hospital between April 1, 1999 andMay 31,
009 (Fig 1). A total of 2112 patients had recorded preop-
rative WBC and did not have a major surgical intervention
ithin 30 days of their vascular procedure. Procedures
xcluded included 234 elective endovascular procedures
nd 249 elective open vascular procedures because there
as no recorded preoperative WBC. Of these, 1773 had
reoperative WBC within the normal range (3.5-10.5
/L), including 804 (45.3%) endovascular cases and 969
54.7%) open cases (Table I). In the endovascular cohort,
he mean age was 71.2 years and the population consisted
f 580 (71.8%) male patients; in the open cohort, the mean
ge was 69.6 years and the population consisted of 617
63.3%) male patients. The endovascular and open cohorts
ere different in mean age and gender distribution, but
ere not significantly different with respect to other co-
orbidities. Both groups had similar mean WBC (7.09 
.57 for endovascular and 7.20  1.65 for open, respec-
ively; P  .17) and illustrated a fairly normal distribution
n WBC data within the normal range.
Mean normal preoperative WBC is associated with
ostoperative complications following endovascular
nterventions. Patients were divided into two cohorts,
ne that experienced complications and one that did not
xperience complications (Table II). In the endovascular
ohort, the mean WBC was significantly higher in the
roup with complications compared with the group with-
ut complications (mean SD: 7.7 1.47 vs 7.1 1.57,
espectively, P  .002). The mean WBC was significantly
igher in the group with MAE compared with the group
ithout MAE (8.3 1.26 vs 7.1 1.57, respectively, P
001). The mean WBC was also significantly higher in the
roup with death compared with the group without death
8.9 1.08 vs 7.1 1.57, respectively, P .004). Analysis
ased on gender was not statistically significant.
In the open cohort, the mean WBC was not signifi-
antly different in the group with complications compared
ith the group without complications (7.2 1.74 vs 7.2
.63, respectively, P  .915). The mean WBC was not
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Volume 54, Number 5 Amaranto et al 1397significantly different in the group with MAE compared
with the group without MAE (7.3  1.86 vs 7.2  1.63,
respectively, P  .643). The mean WBC was also not
significantly different in the group with death compared
Fig 1. Patient population cohort. Procedures included
count (WBC) and were divided into endovascular and o
underwent carotid artery stenting (CAS), endovascular
repair of thoracoabdominal aortic aneurysm (TEVAR), a
included patients who underwent carotid endarterectom
open repair of thoracoabdominal aortic aneurysm (TAA
Table I. Demographics of endovascular and open
vascular cohorts
Endovascular
(n  804)
Open
(n  969) Pa
Age (years, mean 
SD)
71.2  10.4 69.6  10.5 .002
Male gender 580 (71.8%) 617 (63.3%) .001
Diabetes 203 (25.1%) 251 (25.7%) .765
Congestive heart failure
within prior 30 days 14 (1.7%) 26 (2.7%) .185
Myocardial infarction
within prior 6
months 20 (2.5%) 19 (1.9%) .449
Renal insufficiency
(creatinine 1.7
mg/dL) 99 (12.3%) 106 (10.9%) .363
Hypertension 677 (83.8%) 822 (84.3%) .765
Hyperlipidemia 485 (60.0%) 618 (63.4%) .146
Emergent presentation 33 (4.1%) 41 (4.2%) .899
WBC (mean  SD) 7.09  1.57 7.20  1.65 .170
WBC, White blood cell count.
aStudent t test for continuous variables; 2 test for categorical variables.with the group without death (7.1  2.13 vs 7.2  1.63, hespectively, P  .863). Analysis based on gender was not
tatistically significant.
An increasing preoperative WBC predicts postoper-
tive death and complications following endovascular
nterventions. To determine if an increasing normal pre-
perative WBC predicted a greater risk for postoperative
omplications, patients were divided into seven groups,
ach comprising an increment of 1 K/L WBC within the
stablished normal range of 3.5 to 10.5 K/L. The num-
er of patients in the seven groups for the endo-cohort
ere as follows (ie, 3.5-4.5, 4.5-5.5, etc): 32, 92, 182, 184,
47, 98, and 69. The number of patients in the eight
roups for the open cohort were as follows (ie, 3.5-4.5,
.5-5.5, etc): 40, 121, 179, 214, 179, 136, and 100. The
roportion of postoperative complications, MAE, and
eath in each WBC subgroup is illustrated in Fig 2, A-C.
tatistical significance testing was conducted using logistic
egression and the Cochran-Armitage test for trend. In the
ndovascular cohort, there was a significant linear relation-
hip between increasing WBC within the normal range and
he risk of complications, MAE, and death. Univariate
ogistic regression revealed that for every 1 K/L increase
n preoperative WBC, endovascular patients had a 31.4%,
6.8%, and 128.1% increase in their relative odds of devel-
ping postoperative complications (P  .002), MAE (P 
001), and death (P  .015), respectively. Within the
ormal WBC range, as well as, including the abnormally
e analysis had a normal preoperative white blood cell
ohorts. The endovascular cohort included patients who
r of abdominal aortic aneurysm (EVAR), endovascular
wer extremity stenting (LES). The open vascular cohort
A), open repair of abdominal aortic aneurysm (AAA),
nd lower extremity bypass grafting (LEB).in th
pen c
repai
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y (CEighWBC range, the Cochran-Armitage test also showed a
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November 20111398 Amaranto et alsignificant linear trend between the WBC count and post-
operative complications, MAE, and death for the endovas-
cular cohort (Fig 2,A-C). The abnormally lowWBC range
was not included in this analysis because the sample size was
too small (Supplemental Table, online only).
For the open surgical cohort, no notable relationship
between a normal preoperative WBC and postoperative
complications was observed (Fig 2,A). However, we found
a curvilinear U-shaped relation between preoperative nor-
mal WBC and MAE and death (Fig 2, B and C). A curvi-
linear trend test showed a significant P value only for death
(P  .0026) and not for MAE (P  .0698). Further
post-hoc analysis of the univariate logistic regression of the
open surgical cohort revealed that patients in the very low
(3.5-4.4) and very high (9.5-10.5) normal WBC range
were at a significantly higher risk of death (P  .05), but
not MAE. Thus, this relationship was not linear, as ob-
served with the endovascular cohort.
WBC is an independent predictor of postoperat-
ive death and complications following endovascular
interventions. To identify if the WBC or other variables
were independent predictors of outcomes, we performed a
multiple logistic regression analysis on the endovascular
and open patient cohorts (Table III). Because of the curvi-
linear U-shaped relation between WBC and death and
MAE, we also added a quadratic term for the WBC to the
multivariate model for the open patient cohort. In the
endovascular cohort, the WBC was identified as an inde-
pendent predictor of complications (P  .002, odds ratio
[OR]  1.33), MAE (P  .001, OR  1.67), and death
(P  .015, OR  1.82). Other independent predictors of
complications, MAE, or death in the endovascular cohort
included renal insufficiency, CHF, and male gender. In the
open cohort, the WBC was not predictive of complications
(P .544, OR 0.97) or MAE (P .119, OR 1.07 for
the curvilinear trend), but was a significant independent
predictor of death (P .005, OR 1.17 for the curvilinear
trend). Other independent predictors of complications,
MAE, or death in the open cohort included age, CHF,
renal insufficiency, hypertension, and emergent presenta-
tion.
WBC is predictive of outcomes for lower extremity
Table II. Mean WBC in groups with and without complic
With event mean  SD (n) Wi
Endovascular
Complicationsa 7.7  1.47 (55)
MAEb 8.3  1.26 (19)
Death 8.9  1.08 (6)
Open
Complicationsa 7.2  1.74 (133)
MAEb 7.3  1.86 (57)
Death 7.1  2.13 (29)
MAE, Major adverse event; WBC, white blood cell count.
aDeath, stroke, myocardial infarction, transient ischemic attack, infection, b
bDeath, stroke, and myocardial infarction.stents, but is not predictive of outcomes for other dndividual procedures. To investigate our findings fur-
her and determine if the relationship between a normal
reoperative WBC and outcomes was procedure specific,
e conducted both parametric (Student t test) and non-
arametric (Mann-Whitney U test) tests on the individual
rocedures of the endovascular and open cohorts. Within
he normal range, the mean preoperative WBC was only
ignificantly different in the groups with complications
ompared with the groups without complications for MAE
nd death following LES (Table IV). There was a trend
oward complications andMAE following CAS and EVAR.
hese relationships were not significant, possibly due to
mall sample size when these data were separated into
ubgroups.
ISCUSSION
Overall, our analysis revealed a linear relationship be-
ween a normal preoperativeWBC count and postoperative
eath/complications following endovascular interven-
ions, while both a low and high normal preoperative WBC
ount was associated with death following open interven-
ions. Including abnormally elevated preoperative WBC
ounts in the analysis strengthened the relationship be-
ween the WBC and postoperative outcomes for endovas-
ular interventions. Using multiple logistic regression anal-
sis, we also found that theWBC count was an independent
redictor of death in both cohorts but was only predictive
f postoperative complications in the endovascular but not
pen vascular cohort. Finally, our subanalysis revealed that
hese findings are not procedure specific, most likely due to
ur small subanalysis sample size.
Numerous findings from surgical research are consis-
ent with the results of our endovascular cohort analysis,
hich found an association between a normal preoperative
BC and complications.3-7,9,17-20 Our research is also
onsistent with population studies that have suggested
levated WBC to be associated with greater health risks
uch as cardiovascular disease and cancer mortality.1,2,22-30
or example, an epidemiologic study found that mortality
ates are as much as 2.5 times greater among healthy men
ith WBC above 9 K/L than for those with lower WBC
n the general population.22 For patients who have already
s
event mean  SD (n) Student t test M-W U test
1  1.57 (753) 0.002 0.002
1  1.57 (789) 0.001 0.001
1  1.57 (802) 0.004 0.006
2  1.63 (842) 0.915 0.831
2  1.63 (918) 0.643 0.721
2  1.63 (946) 0.863 0.751
g, reoperation, and amputation.ation
thout
7.
7.
7.
7.
7.
7.eveloped coronary artery disease or suffered an MI, high
a
h
i
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Volume 54, Number 5 Amaranto et al 1399baseline WBC increases the risk of mortality and the onset
of congestive heart failure.31,32 WBC has been linked to
mortality and major complications of PCI and peripheral
Fig 2. A, Postoperative complication rate by white bloo
vascular (Open) cohorts. Within the normal WBC range
between the WBC count and postoperative complication
.12, P  .9053) group. Including the abnormally h
significant linear trend between the WBC count and post
but not the Open (Z .76, P .4470) group. B, Postop
open vascular (Open) cohorts. Within the normal WBC
trend between the WBC count and postoperative MAE f
.55, P .5805) group. Including the abnormally high W
linear trend between theWBC count and postoperative c
Open (Z  .50, P  .6157) group. C, Postoperative d
vascular (Open) cohorts. Within the normal WBC range
between theWBC count and postoperativemortality for t
P  .9287) group. Including the abnormally high WBC
linear trend between the WBC count and postoperative c
Open (Z  .16, P  .8707) group.artery angioplasty, but every study we reviewed included lbnormal WBC in their analyses.3-7,9,17-21 Other studies
ave linked revascularization to leukocyte activation and an
ncreased inflammatory response.33,34 In fact, we did ana-
l count (WBC) count for endovascular (Endo) and open
Cochran-Armitage test shows a significant linear trend
he Endo (Z 3.02, P .0025), but not the Open (Z
BC range, the Cochran-Armitage test also shows a
tive complications for the Endo (Z 4.84, P .0001),
e MAE rate by WBC count for endovascular (Endo) and
e, the Cochran-Armitage test shows a significant linear
e Endo (Z  3.62, P  .0093), but not the Open (Z 
ange, the Cochran-Armitage test also shows a significant
cations for the Endo (Z 5.24, P .0001), but not the
ate by WBC count for endovascular (Endo) and open
Cochran-Armitage test shows a significant linear trend
do (Z 2.92, P .0035), but not theOpen (Z.09,
ge, the Cochran-Armitage test also shows a significant
ications for the Endo (Z 3.77, P .0002), but not ford cel
, the
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November 20111400 Amaranto et almally elevated preoperative WBC and postintervention
outcomes and found a strong positive association for both
open and endovascular interventions, supporting the pub-
lished literature. Our results from analyzing preoperative
normal values confirm the impact of the preoperative WBC
on postoperative major complications and establish for the
first time that a WBC within the normal range is by itself
predictive of outcomes following vascular interventions.
Results from our open cohort are not consistent with
research that has focused on coronary artery bypass grafts
(CABG).3-5,7 We found that both very high and very low
normal WBC counts were predictive of postoperative
death, but not postoperative complications. However,
Dacey et al analyzed preoperative normal and abnormal
WBC of patients undergoing CABG and noted a linear
relationship betweenmortality and increasingWBC.5 Their
results not only revealed that mortality was 2.8 times higher
among patients with an abnormally elevated WBC (12
K/L) compared with patients with low preoperative
WBC (6.0 K/L), but also showed that mortality was
1.7 times greater for patients with elevated normal preop-
erative WBC (8.0-9.9 K/L) compared with patients with
low preoperative WBC.5 A possible explanation for these
differences is provided by Newall et al, who showed an
abnormally elevated WBC prior to CABG was indepen-
dently associated with increased cardiac enzyme release and
myocardial tissue damage—these outcomes are not neces-
sarily related to the open procedures in our analysis, which
were all noncardiac.7
The clinical relevance of these findings is demonstrated
by examining an important study by Arnaoutoglou et al
that documented cases of patients who developed post
implantation syndrome (PIS) and systemic inflammatory
response syndrome (SIRS) following EVAR.35 They doc-
umented perioperative laboratory data that showed that at
Table III. Multiple logistic regression analysis for indepen
death
Predictor
Endovascular
Complicationsa MAEb
Odds
ratio P
Odds
ratio P
O
ra
WBC (linear) 1.325 .002 1.672 .001 1
WBC (quadratic)    
Age 1.020 .170 1.031 .201 1
Gender (male) 0.747 .345 0.411 .066 0
Diabetes 1.570 .141 1.342 .550 0
Congestive heart failure 3.788 .049 9.009 .007 13
Myocardial infarction 0.137 .182 0.277 .395 1
Renal insufficiency 3.226 .001 3.390 .022 2
Hypertension 1.404 .469 1.511 .618 1
Hyperlipidemia 1.153 .635 1.178 .732 0
Emergent presentation 1.508 .510 1.276 .804 1
MAE, Major adverse event; WBC, white blood cell count.
aDeath, stroke, myocardial infarction, transient ischemia attack, infection, b
bDeath, stroke, and myocardial infarction.least half of the patients who developed PIS had preopera- eive WBC in the elevated normal range (7.5-10.5 K/L).
he authors were not able to identify specifically what
actors may have caused PIS and SIRS in their patients, but
id call for closer monitoring of post-EVAR patients and
or further investigation of potential risk factors. It is pos-
ible that an elevatedWBCwithin the current normal range
ould be an important risk factor for PIS, and this could
ccount for our association of the preoperative WBC with
ntervention outcomes. It is also possible that since the
hysiological insult with endovascular interventions is min-
mal compared to open interventions, that the preoperative
BC is a more important predictor of subsequent out-
omes. Conversely, with open surgery, since the physiolog-
cal insult is much greater, this may explain why very high
nd very low normal WBC counts are associated with
ostoperative death. So many other factors must be consid-
red with open vascular interventions that the preoperative
BC may no longer be important. While our data may
uggest that the upper limit of the normal range of WBC
hould be reconsidered, we must caution the reader that
ur study is retrospective in nature. Further investigations
ould be necessary before implementing changes like this.
owever, these data should bring increasing awareness to
hysicians of this linear association between the preopera-
ive normal WBC and postoperative outcomes following
ndovascular interventions, and very high and low normal
BC counts and postoperative death with open interven-
ions. We also hope that our data lead to further analyzes of
arger data sets as well as a prospective study where other
mportant parameters can be investigated, such as theWBC
ifferential, the neutrophil/leukocyte ratio, and the trend
f the WBC over many days.
Integrating data such as a preoperative WBC into an
ccurate and quantitative risk assessment is important as the
elevance of WBC to outcomes is becoming increasingly
predictors of postoperative complications, MAE, and
Open
th Complicationsa MAEa Death
P
Odds
ratio P
Odds
ratio P
Odds
ratio P
.015 0.965 .544 0.580 .105 0.318 .009
   1.070 .119 1.168 .005
.590 1.007 .452 1.039 .008 1.049 .015
.017 1.055 .787 1.348 .314 1.956 .136
.688 0.780 .280 0.792 .489 0.749 .555
.030 2.793 .025 2.653 .082 4.310 .032
.735 1.218 .753 2.142 .262 2.324 .338
.237 3.906 .001 3.187 .001 5.179 .001
.602 1.087 .765 0.601 .154 0.294 .005
.092 0.718 .096 1.001 .997 0.696 .352
.564 2.217 .037 3.194 .0115 4.203 .009
g, reoperation, and amputation.dent
Dea
dds
tio
.824

.018
.155
.722
.699
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.972
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The Vascular Biochemistry and Hematology Outcome
Models (VBHOM) attempts to identify a minimal objec-
tive data set that can predict outcome following vascular
interventions.37,38 Tang et al determined from a derivation
and validation set that gender, mode of admission, age,
urea, sodium, potassium, hemoglobin, WBC, creatinine,
and urea/creatinine successfully predicted surgical mortal-
ity. Our research strengthens the relevance of the VBHOM
because WBC is one of the variables used in the model.
The scope of this research was limited by several factors.
It was a retrospective study of a single center and did not
include late complications. Due to the nature of retrospec-
tive data collection, some demographic and outcome data
were not able to be captured, limiting the extent of our
analysis and conclusion. For example, we were not able to
perform an analysis on the WBC differential because these
data were not sufficiently and consistently obtained or
recorded in the medical records of our patients. We also
Table IV. Normal preoperative WBC count and postoper
With event mean  SD (n) W
Endovascular
CAS
Complications a 8.0  1.32 (12)
MAE b 8.7  1.10 (3)
Death 8.6  n/a (1)
EVAR
Complications a 7.6  1.45 (17)
MAE b 7.4  1.26 (6)
Death 8.6  1.27 (2)
TEVAR
Complications a 8.0  1.57 (9)
MAE b 8.3  1.37 (5)
Death 9.1  1.98 (2)
LES
Complications a 7.6  1.61 (17)
MAE b 9.1  0.65 (5)
Death 9.1  0.07 (2)
Open
CEA
Complications a 7.4  1.69 (20)
MAE b 7.0  1.81 (14)
Death 6.3  1.34 (6)
AAA
Complications a 6.9  1.57 (40)
MAE b 7.0  1.84 (15)
Death 6.7  2.25 (8)
TAAA
Complications a 6.8  1.87 (33)
MAE b 7.2  1.91 (13)
Death 7.2  2.24 (9)
LEB
Complicationsa 7.7  1.76 (40)
MAE b 8.0  1.88 (15)
Death 8.6  2.20 (6)
AAA, Open repair of abdominal aortic aneurysm; CAS, carotid artery stent
aortic aneurysm; LEB, lower extremity bypass; LES, lower extremity sten
aneurysm; TEVAR, endovascular repair of thoracoabdominal aortic aneurys
aDeath, stroke, myocardial infarction, transient ischemic attack, infection, b
bDeath, stroke, and myocardial infarction.were not able to conduct an analysis of the effect of preop- trative medications on the preoperative WBC. Because
nly one preoperativeWBCwas included in our analysis for
ach procedure, preoperative trends in WBC could not be
ccounted for. This limitation may have caused patients
ith inflammation who were quickly trending upwards to
e included in the normal WBC group. We also did not
nalyze the influence of postoperative WBC on outcomes,
ince this was not the intent of this manuscript. Our results
howed a strong trend that did not reach significance
etween preoperative normal WBC and outcomes of indi-
idual endovascular procedures. The lack of significance for
his trend is most likely attributable to a low sample size
hen subanalyzing our data. Other components of blood
hat contribute to inflammation, such as C-reactive protein
CRP), ESR, and platelets, were not included in the analysis
iven that this was a retrospective review, and these data
ere not available on many patients. If these data were
vailable, analysis of these variables may have uncovered a
elationship between CRP, ESR, or platelets and the WBC
complications by procedure
t event mean  SD (n) Student t test M-W U test
.1  1.55 (176) 0.053 0.048
.1  1.54 (185) 0.080 0.073
.1  1.55 (187) n/a n/a
.9  1.55 (326) 0.063 0.070
.9  1.56 (337) 0.426 0.345
.9  1.55 (341) 0.142 0.112
.2  1.79 (71) 0.215 0.188
.2  1.79 (75) 0.175 0.170
.2  1.76 (78) 0.142 0.152
.3  1.51 (180) 0.493 0.3927
.3  1.50 (192) 0.002 0.006
.3  1.51 (195) 0.001 0.086
.1  1.65 (435) 0.492 0.536
.1  1.64 (441) 0.741 0.601
.1  1.65 (449) 0.201 0.183
.5  1.66 (186) 0.386 0.413
.1  1.64 (211) 0.831 0.870
.1  1.62 (218) 0.437 0.429
.9  1.60 (38) 0.826 0.729
.8  1.68 (58) 0.493 0.444
.8  1.65 (62) 0.595 0.592
.5  1.55 (183) 0.605 0.602
.5  1.56 (208) 0.282 0.304
.5  1.56 (217) 0.110 0.128
, carotid artery endarterectomy; EVAR, endovascular repair of abdominal
E, major adverse event; TAAA, open repair of thoracoabdominal aortic
BC, white blood cell count.
g, reoperation, and amputation.ative
ithou
7
7
7
6
6
6
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
7
7
7
; CEA
t; MA
m; What might account for our findings. Correlation of the
11
1
1
1
1
1
1
1
1
2
2
2
2
2
2
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November 20111402 Amaranto et alWBC to statin use was also not analyzed, since this study
spanned from 1999 to 2009. Many patients in the early
years of this study were not taking statins. Last, we did not
include data on race in our analysis since this information
was not available on all patients. It has been pointed out
that epidemiologic differences contribute to WBC and risk
of adverse outcomes.39
In conclusion, our study identified that an increased
preoperative WBC within the normal range is an indepen-
dent predictor of postoperative complications and death
following endovascular intervention. While we did not find
a significant relationship between normal WBC and post-
operative complications in the open vascular surgery co-
hort, we did find an association with very low and very high
WBC counts and death following open interventions. This
study suggests that the inflammatory response is of rela-
tively greater concern for vascular interventions. Further-
more, our data suggest that outcomes models based on
minimal data sets may be used to mitigate surgical risk if
they are structured to incorporate preoperative WBC.
Overall, we believe the findings from our study warrant
further investigation into the predictive nature of a normal
preoperative WBC in a large prospective study.
AUTHOR CONTRIBUTIONS
Conception and design: MK
Analysis and interpretation: DA, EW, WP, MK
Data collection: DA, ME, MM, HR, MK
Writing the article: DA, WP, MK
Critical revision of the article: DA, EW, ME, MM, HR,
WP, MK
Final approval of the article: DA, EW, ME, MM, HR, WP,
MK
Statistical analysis: DA, EW, WP, MK
Obtained funding: Not applicable
Overall responsibility: MK
REFERENCES
1. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and
coronary heart disease: implications for risk assessment. J Am Col
Cardiol 2004;44:1945-56.
2. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO,
III, Criqui M, et al. Markers of inflammation and cardiovascular disease:
application to clinical and public health practice: a statement for health-
care professionals from the Centers for Disease Control and Prevention
and the American Heart Association. Circulation 2003;107:499-511.
3. Albert A, Beller C, Walter J, Arnrich B, Rosendahl U, Priss H, et al.
Preoperative high leukocyte count: a novel risk factor for stroke after
cardiac surgery. An Thorac Surg 2003;75:1550-7.
4. Bhatt DL, Chew DP, Lincoff AM, Simoons ML, Harrington RA,
Ommen SR, et al. Effect of revascularization on mortality associated
with an elevated white blood cell count in acute coronary syndromes.
Am J Cardiol 2003;92:136-40.
5. Dacey LJ, DeSimone J, Braxton JH, Leavitt BJ, Lahey SJ, Klemperer
JD, et al. Preoperative white blood cell count and mortality and mor-
bidity after coronary artery bypass grafting. Ann Thorac Surg 2003;76:
760-4.
6. Gurm HS, Bhatt DL, Gupta R, Ellis SG, Topol EJ, Lauer MS, et al.
Preprocedural white blood cell count and death after percutaneous
coronary intervention. Am Heart J 2003;146:692-8.7. Newall N, Grayson AD, Oo AY, Palmer ND, Dihmis WC, Rashid A, et
al. Preoperative white blood cell count is independently associated with
2higher perioperative cardiac enzyme release and increased 1-year
mortality after coronary artery bypass crafting. Ann Thorac Surg
2006;81:583-9.
8. Gu YJ, deVries AJ, Boonstra PW, van Oeveren W. Leukocyte depletion
results in improved lung function and reduced inflammatory response
after cardiac surgery. J Thoracic Cardiovasc Surg 1996;112:494-500.
9. Toor IS, Jaumdally RJ, Moss MS, Babu SB. Preprocedural neutrophil
count predicts outcome in patients with advanced peripheral vascular
disease undergoing percutaneous transluminal angioplasty. J Vasc Surg
2008;48:1504-8.
0. Kasper DL, Braunwald E, Hauser S, Longo D, Jameson JL, Fauci AS.
Disorders of granulocytes and monocytes. Harrison’s principles of
internal medicine. 16th ed. New York, NY: McGraw-Hill Professional;
2005. p. 349.
1. Complete Blood Count (CBC) with 5-Part Differential; National
Health and Nutrition Examination Survey (NHANES). 2003-2004
Data Documentation, Codebook, and Frequencies. 2010. Available at:
http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/L25_C.htm.
Accessed February 1, 2010.
2. Haugen S, Casserly IP, Regensteiner JG, Hiatt WR. Risk assessment in
the patient with established peripheral arterial disease. Vasc Med 2007;
12:343-50.
3. Kannel WB, Anderson K, Wilson PW. White blood cell count and
cardiovascular disease. Insights from the Framingham Study. JAMA
1992;267:1253-6.
4. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis.
Circulation 2002;105:1135-43.
5. Rader DJ. Inflammatory markers of coronary risk. N Engl J Med
2000;343:1179-82.
6. Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med 1999;
340:115-26.
7. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL, et al.
Usefulness of an elevated neutrophil to lymphocyte ratio in predicting
long-term mortality after percutaneous coronary intervention. Am J
Cardiol 2006;97:993-6.
8. Jurewitz DL, Pessegueiro A, Zimmer R, Bhatia R, Tobis J, Lee MS, et
al. Blood cell count as a predictor of death and major adverse cardiac
events in patients undergoing percutaneous coronary intervention with
drug-eluting stents. J Invasive Cardiol 2009;5:202-6.
9. Kruk M, Karcz M, Przyłuski J, Bekta P, Kepka C, Kalin´czuk Ł, et al.
White blood cell count adds prognostic information to the thrombolysis
in myocardial infarction risk index in patients following primary percu-
taneous coronary intervention (ANIN Myocardial Infarction Registry)
(White blood cell count adds prognostic information to the thrombol-
ysis in myocardial infarction risk index in patients following primary
percutaneous coronary intervention [ANINMyocardial Infarction Reg-
istry]). Int J Cardiol 2007;116:376-82.
0. Upadhya B, Applegate RJ, Sane DC, Deliargyris EN, Kutcher MA,
Gandhi SK, et al. Preprocedural white blood cell count and major
adverse cardiac events late after percutaneous coronary intervention in
saphenous vein grafts. Am J Cardiol 2005;96:515-8.
1. Prasad A, Stone GW, Stuckey TD, Costantini CO,Mehran R, Garcia E,
et al. Relation between leucocyte count, myonecrosis, myocardial per-
fusion, and outcomes following primary angioplasty. Am J Cardiol
2007;99:1067-71.
2. De Labry LO, Campion EW, Glynn RJ, Vokonas PS. White blood cell
count as a predictor of mortality: results over 18 years from the
normative aging study. J Clin Epidiemol 1990;43:153-7.
3. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE.
Prospective study of hemostatic factors and incidence of coronary heart
disease: The Atherosclerosis Risk in Communities (ARIC) Study. Cir-
culation 1997;96:1102-8.
4. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a
predictor of myocardial infarction. N Engl J Med 1974;290:1275-8.
5. Grimm RH Jr, Neaton JD, Ludwig W, Multiple Risk Factor Interven-
tion Trial Research Group. Prognostic importance of the white blood
cell count for coronary, cancer, and all-cause mortality. JAMA 1985;
254:1932-7.6. Hansson GK. Inflammation, atherosclerosis, and coronary artery dis-
ease. N Engl J Med 2005;352:1685-95.
33
3
3
3
3
S
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 5 Amaranto et al 140327. Rana JS, Boekholdt SM, Ridker PM, Jukema JW, Luben R, Bingham
SA, et al. Differential leucocyte count and the risk of future coronary
artery disease in healthy men and women: the EPIC-Norfolk Prospec-
tive Population Study. J Intern Med 2007;262:678-89.
28. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benja-
min EJ, et al. Inflammatory markers and risk of heart failure in elderly
subjects without prior myocardial infarction: the Framingham Heart
Study. Circulation 2003;107:1486-91.
29. Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O’Brien JR, White-
head PJ, et al. Fibrinogen, viscosity, and white blood cell count are
major risk factors for ischemic heart disease. The caerphilly and speed-
well collaborative heart disease studies. Circulation 1991;83:836-44.
30. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen,
C-reactive protein, albumin, or leukocyte count with coronary heart
disease: meta-analyses of prospective studies. JAMA 1998;279:
1477-82.
31. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM.
Association between white blood cell count, epicardial blood flow,
myocardial perfusion, and clinical outcomes in the setting of acute
myocardial infarction: a thrombolysis in myocardial infarction 10 sub-
study. Circulation 2000;102:2329-34.
32. Grzybowski R, Welch R, Parsons L, Ndumele C, Chen E, Zalenski R, et
al. The association between white blood cell count and acutemyocardial
infarction in-hospital mortality: findings from the national registry of
myocardial infarction. Acad Emerg Med 2004;11:1049-60.
33. Mickelson JK, Lakkis NM, Villarreal-Levy G, Hughes BJ, Smith CW.
Leukocyte activation with platelet adhesion after coronary angioplasty:
a mechanism for recurrent disease? J Am Col Cardiol 1996;28:345-53. a4. SerranoMD, Ramires MFJA, Venturinelli BS, Arie MD, D’AmicoMD,
ZweierMD, et al. Coronary angioplasty results in leukocyte and platelet
activation with adhesionmolecule expression: evidence of inflammatory
responses in coronary angioplasty. J AmCol Cardiol 1997;29:1276-83.
5. Arnaoutoglou E, Papas N, Milionis H, Kouvelos G, Koulouras V,
Matsagkas MI, et al. Post-implantation syndrome after endovascular
repair of aortic aneurysms: need for postdischarge surveillance. Interact
Cardiovasc Thorac Surg 2010;11:449-54.
6. Prytherch DR, Ridler B, Ashley S. Risk-adjusted predictive models of
mortality after index arterial operations using a minimal data set. Br J
Surg 2005;92:714-8.
7. Tang TY, PrytherchDR,Walsh SR, Athanassoglou V, Seppi V, Sadat U,
et al. The development of a VBHOM-based outcome model for lower
limb amputation performed for critical ischaemia. Eur J Vasc Endovasc
Surg 2009;37:62-6.
8. Tang T, Walsh S, Prytherch D, Lees T, Varty K, Boyle J, et al. A data
economic model for predicting the outcome after open abdominal
aortic aneurysm surgery. Br J Surg 2007;94:717-21.
9. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy
JA. Leukocytes and the risk of ischemic diseases. JAMA 1987;257:
2318-24.
ubmitted Nov 1, 2010; accepted April 30, 2011.
Additional material for this article may be found online
t www.jvascsurg.org.
JOURNAL OF VASCULAR SURGERY
November 20111403.e1 Amaranto et alSupplemental Table (online only). Number of events fo
WBC range
WBC Range
Abnormal WBC
1.5 1.5-2.4 2.5-
Total no. of subjects
Endo 1 3 7
Open 0 4 4
Complications
Endo 1 0 0
Open 0 0 1
MAE
Endo 1 0 0
Open 0 0 0
Death
Endo 0 0 0
Open 0 0 0
MAE, Major adverse event; WBC, white blood cell count.r endovascular and open complications, MAE, and death per
Normal WBC range
3.4 3.5-4.4 4.5-5.4 5.5-6.4 6.5-7.4
32 92 182 184
40 121 179 214
0 3 8 12
5 22 24 22
0 0 1 3
3 8 10 10
0 0 0 0
3 4 6 4
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Normal WBC range Abnormal WBC
7.5-8.4 8.5-9.5 9.5-10.5 10.5-11.4 11.5-12.4 12.5-13.4 13.5-14.4
147 98 69 42 27 16 16
179 136 100 59 47 14 23
17 7 6 6 3 2 4
23 22 14 10 9 2 3
6 5 3 3 2 1 3
6 11 8 3 3 0 2
2 2 1 1 1 0 2
2 3 7 1 1 0 1Supplemental Table (online only). Continued.
Abnormal WBC
14.5-15.4 15.5-16.4 16.5-17.4 17.5-18.4 18.5-19.4 19.5-20.4 20.5-21.4
6 4 4 6 2 1 3
11 8 7 4 2 4 1
1 1 0 2 2 0 2
4 2 0 0 0 0 0
1 1 0 0 1 0 1
2 1 0 0 0 0 0
0 0 0 0 1 0 1
2 0 0 0 0 0 0Supplemental Table (online only). Continued.
Abnormal WBC
21.5-22.4 22.5-23.4 23.5-24.4 25.5-26.4 26.5-27.4 27.4
1 2 0 1 2 1
2 0 2 1 0 1
1 1 0 1 0 0
1 0 1 0 0 0
1 0 0 0 0 0
0 0 1 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
